Source: Applied Clinical Trials

OmniComm: FGK Clinical Research Signs Five-Year Agreement with OmniComm Systems

FGK Clinical Research GmbH has entered into a multi-year partnership with OmniComm Systems, Inc. Under the terms of the agreement, FGK will use TrialMaster electronic data capture , IRTMaster, and Acuity Analytics along with other related products/services to supplement FGK s clinical trial op

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Stephen E Johnson's photo - President & CEO of OmniComm

President & CEO

Stephen E Johnson

CEO Approval Rating

68/100

Read more